Caribou Biosciences Inc
CRBU
Get informed when a big investor buys or sells
+ FollowMarket Cap$125.96M
Close$
$-1.97
255.5% downside
Current Fair Value
255.5% downsideOvervalued by 255.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $125.96 Million |
|---|---|
| Enterprise Value | $126.79 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.59 |
| Beta | 2.28 |
| Outstanding Shares | 100,985,698 |
Return
| Return on Equity | -105.40% |
|---|---|
| Return on Assets | -72.42% |
| Return on Invested Capital | -87.08% |
Valuation & Multiples
| P/E Ratio | -1.18 |
|---|---|
| PEG | 2.13 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 23.31 |
| Enterprise Value to EBIT | -1.17 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
$2.28 M
Average shareholder expectationNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
$-0.36
Average shareholder expectationRevenue Estimate
$2.20 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3989▲ 1.61% |
|---|---|
| Total Calls | 229,400▼ 27.20% |
| Total Puts | 91,500▼ 24.13% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 48.77%▲ 9.29% |
|---|---|
| Total Invested | $86.26M▲ 20.93% |
| Investors Holding | 145▲ 3.00% |
ESG Score
No data
About Caribou Biosciences Inc
2,021 employees